|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07F 9/6561 | (2006.01) |
| C07F 9/65616 | (2013.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Patento numeris | 3503895 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17844238.0 |
| Europos patento paraiškos padavimo data | 2017-08-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/047892 |
| Data | 2017-08-22 |
| (87) | Numeris | WO 2018/039157 |
| Data | 2018-03-01 |
| (30) | Numeris | Data | Šalis |
| 201662379455 P | 2016-08-25 | US |
| (72) |
DA COSTA, Daniel , FR
DOUSSON, Cyril, B. , FR
DUKHAN, David , FR
PAPARIN, Jean-Laurent , FR
RAHALI, Houcine , FR
RAHEEM, Izzat , US
|
| (73) |
Merck Sharp & Dohme Corp. ,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
Idenix Pharmaceuticals LLC , 320 Bent Street, Cambridge, MA 02141, US |
| (54) | ANTIVIRAL PRODRUGS OF TENOFOVIR |
| ANTIVIRAL PRODRUGS OF TENOFOVIR |